Generic Sildenafil Economics
The post-2017 price collapse and GoodRx cash-pricing of generic Viagra
Evidence grade 5 of 5, Settled. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- FDA Approved (generic sildenafil, Dec 2017)
Reference only. Not medical advice.
What can go wrong
Cheap access is good, but price opacity is the catch: the same generic can cost a few dollars at one pharmacy and tens of dollars at another. Patients who buy 'sildenafil' from unverified overseas websites risk counterfeit or contaminated product. A low price does not remove the nitrate contraindication or the need to treat ED as a possible cardiovascular signal.
This is something to take to a clinician. The Atlas can tell you what is known about generic sildenafil economics in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
When Teva launched generic sildenafil in December 2017, the cash price of an ED dose began a steep decline. With manufacturer competition and discount-coupon platforms like GoodRx, generic sildenafil 20mg/25mg/50mg can cost cash-pay patients a small fraction of branded Viagra. Yet pricing remains wildly inconsistent: GoodRx's own research has documented ED-medication price differences exceeding 1,000% between pharmacies for the same drug.
How a $50 pill became a $0.30 commodity, and why some still pay $70.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
Generic competition works by removing patent exclusivity: once multiple manufacturers can make sildenafil, marginal production cost (cents per tablet) sets the floor, and pharmacies/PBMs/coupon aggregators compete on cash price. The 20mg sildenafil tablet (originally marketed as Revatio for pulmonary hypertension) became a popular low-cost route to an effective ED dose.
Why the prices still vary so much
Cash prices for an identical generic are set by opaque pharmacy/PBM contracts, not by the drug's cost. GoodRx and similar coupons arbitrage these contracts. The result: a rational shopper can pay under a dollar a pill, while an uninformed one pays 10-50x more for the same molecule, and telehealth brands price against that confusion.
What people get wrong
Often saidGeneric sildenafil is weaker or lower quality than Viagra
ActuallyFDA-approved generic sildenafil must meet bioequivalence standards. The difference is price and packaging, not efficacy.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
Set against the alternatives
Branded Viagra (Pfizer) and Cialis (Lilly) still command premium prices; generic sildenafil and tadalafil are the value tier; the 20mg sildenafil (Revatio-equivalent) tablet is a well-known low-cost workaround clinicians sometimes use.
At a glance
- Generic launch
- December 2017 (Teva first)
- Branded Viagra (historical)
- ~$50-$70+ per pill
- Generic cash price
- Often a few dollars or less per pill with coupons
- Price spread
- GoodRx documented ED-med price gaps over 1,000% between pharmacies
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Generic Sildenafil Economics. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.